Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

Animal Testing And Non-Animal Alternative Testing Market 2024 – By End Use Industrial Application (Basic Research, Applied Research, Regulatory Testing, Development Of New Diagnostic Methods, Breeding Of Genetically Altered Animals, Animal Cloning), By End-Use Industry (Pharmaceutical, Academic Research, Medical Devices, Chemicals And Pesticides, Cosmetics, Other End Users), By Animal Type (Mice, Rats, Frogs, Fish, Birds, Guinea Pigs, Hamsters, Rabbits, Sheep, Dogs, Cats, Monkeys, Pigs, Others), And By Region, Opportunities And Strategies – Global Forecast To 2035

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

Starting Price : $5000.00 | Pages : 259 | Published : April 2024 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2032

Proud Members Of

checkslacipN checkaoirsN checkscipN

Animal Testing And Non-Animal Alternative Testing Market Definition

Animal testing or in-vivo testing is the use of living animals in scientific experiments to assess the safety and effectiveness of new products developed in the biopharma, medical devices, chemicals, food and other industries. Animal testing allows scientists to understand how the human body might react to specific substances. The study on animals is a vital part of the research because the basic cell process and physiology of animals is similar to that of humans.  

Non-animal alternative testing technologies include those technologies such as in-vitro cell and tissue cultures, organs-on-chips (OOCs), computer simulations, 3D bioprinting of tissues and synthetic skin substitutes.  These technologies replace animal testing in end-use industries including pharmaceuticals, medical devices, chemicals and pesticides, food and others.

Animal Testing And Non-Animal Alternative Testing Market Size

Animal Testing

The global animal testing market was valued at $10.74 billion in 2019 and the market is expected to grow at a compound annual growth rate (CAGR) of 1.03% during 2023-2028 and at a CAGR of 2.64% during 2028-2035. USA and Japan are the major animal testing markets in the world. The USA’s animal testing market was valued at $4.67 billion in 2019, and is expected to grow at a CAGR of 0.42% during 2023-2028 and at a CAGR of 0.81% during 2028-2035. Japan’s animal testing market was valued at $1.03 billion in 2019. The market is forecast to grow at a CAGR of 0.99% during 2023-2028, and at a CAGR of 1.66% during 2028-2035.

The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2021 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2021, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.

Non-Animal Alternative Testing

The global non-animal alternative testing market was valued at $1.11 billion in 2019. The market is expected to grow at a CAGR of 6.34% during 2023-2028. The USA’s non-animal alternative testing technology market was valued at $0.34 billion in 2019. The USA’s market is forecast to grow at a CAGR of 6.39% through during 2023-2028. Japan's non-animal alternative testing technology market was valued at $0.06 billion in 2019 and the market is forecast to grow at a CAGR of 4.14% through 2023-2028.

The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2026 post regulatory agencies’ validation and approval.

Animal Testing And Non-Animal Alternative Testing Market Drivers

The key drivers of the animal testing and non-animal alternative testing market include:

Increasing Investment In R&D By The Pharmaceutical Companies (Animal Testing)

The rise in investment in R&D (research and development) by the pharma companies leads to the growth of the animal testing market. The rate of investment has been increasing over the years and pharmaceutical companies are the top investors in R&D. The key factor for research-based pharmaceutical companies investing more in R&D is the discovery and development of new drugs serving unmet medical needs. For FY20-21, the average R&D expenses of pharma companies in India were 7.2% of total revenues, with Lupin, Alembic Pharma and Dr. Reddy's spending more than others. The top 20 global pharmaceutical companies collectively spent $139 billion on R&D in 2022.  Roche, a Swiss healthcare company, spent 14.05 billion Swiss francs ($15.15 billion) on R&D in 2022. For example, the global pharmaceutical companies collectively spent $139 billion on research and development in 2022.  Also in 2019, globally pharmaceutical companies spent an average of roughly 25% of their revenue on R&D, according to federal government statistics.  Therefore, the increasing investment in animal models will be widely employed in pharmaceutical research. This is expected to drive the animal testing market.

Increasing Adoption Of In-Vitro and In-Silico Technologies In Basic Research By Pharmaceutical Industry (Non-Animal testing)

The significant advancement of in-vitro and in-silico testing methods that led to the adoption of alternatives to animal testing by pharmaceutical companies for basic research studies contributed to the growth of the non-animal testing market. New in-vitro technologies such as organ-on-chip (OOC) and in-silico technology such as computer-aided modeling technologies are trying to replace whole-animal testing in the drug development life cycle.  For instance, People for the Ethical Treatment of Animals (PETA), researchers have created “organs-on-chips” that contain human cells grown in a state-of-the-art system to mimic the structure and function of human organs and organ systems. The chips can be used instead of animals in disease research, drug testing and toxicity testing and have been shown to replicate human physiology, diseases and drug responses more accurately than crude animal experiments do. Some companies, such as AlveoliX, MIMETAS and Emulate, Inc., have already turned these chips into products that other researchers can use in place of animals.  Further in October 2023, Piramal Pharma Solutions, a leading US-based multi-product facility that has been manufacturing antibody-drug conjugates (ADCs) and other bioconjugates, launched in-vitro biology capabilities at its Ahmedabad Discovery Services Site, based in India. The expansion couples new biology services with existing chemistry capabilities, bringing added value to customers by providing an integrated set of discovery capabilities. The expansion includes a world-class high-throughput screening facility that augments the existing in-vitro screening technology. The new high-throughput screening format enables Piramal Pharma Solutions to evaluate and screen large collections using various platforms, including TR-FRET, absorbance, Luminescence/Electrochemiluminescence, AlphaScreen, LanthaScreen, flow cytometry and high-content imaging.

Animal Testing And Non-Animal Alternative Testing Market Restraints

The key restraints on the animal testing and non-animal alternative testing market include:

High Cost Of Animal Studies (Animal Testing)

The high cost associated with animal testing is challenging the growth of this market. The total cost of animal use in research studies is the sum of the cost of acquisition of the animals and that of maintaining the animals prior to and during their use. The maintenance cost and the actual cost for a particular species vary with the sex, strain, weight, age, quantity ordered, method of shipping and distance shipped.  According to an animal supply company, New Zealand White Rabbits cost as high as $352 each, purebred Beagles for $1,049 and some primates costing more than $8,000 each.  Additionally, there is human labor cost, as the animals need an attendant. Therefore, the high cost of animal studies is hindering the animal testing market and, in a way, boosting the adoption of alternative testing methods.

Long Duration For Validation Of Non-Animal Testing Technologies (Non-Animal Testing)

The process of validation of the new alternative technology is taking time, which will reduce the acceptance of new technologies by the end-use industries. The current agencies that are responsible for validation take a long time to approve new alternative technologies. For instance, skin corrosivity is one of the simplest adverse events in the in-vitro tests. This test has taken around 20 years to get acceptance from the organization for economic cooperation and development (OECD) addressing the endpoint. Hence, a long period of validation of these novel technologies will result in the tests becoming outdated before they are validated and hinders the alternative technologies market.

Animal Testing And Non-Animal Alternative Testing Market Trends

Major trends shaping the animal testing and non-animal alternative testing market include:

AI To Accelerate Drug Discovery Technologies With Ethical Alternatives

Major non-animal testing technologies companies are focusing on AI (artificial intelligence) to accelerate drug discovery technologies with ethical alternatives to expand their businesses. AI plays a crucial role in enhancing the capabilities of both animal testing and non-animal alternative testing methods, ultimately advancing biomedical research while reducing the ethical concerns and limitations associated with animal experimentation. For example, in June 2023, Quantiphi, a US-based AI-driven digital engineering company, launched Digital Animal Replacement Technology (DART), which is a solution that offers a humane and accurate alternative to traditional animal testing for drug discovery, manufacturing and pre-clinical trials. DART combines human biology with advanced digital technologies to predict drug safety and efficacy accurately, eliminating the need for animal testing in many scenarios. The technology uses ethically sourced human stem cells, a Digital Workstation and AI to accelerate drug discovery while ensuring safety and efficacy. DART's launch represents a significant step towards more ethical, efficient and effective alternatives to animal testing in the pharmaceutical industry.

Adoption Of In Silico Trials To Test Efficacy Of Drugs

The use of in silico trials for testing is another trend in the non-animal alternatives testing market. In silico means “performed on computer or via computer simulation”, in modern science it refers to experimental techniques performed by computers. The in-silico trials use artificial intelligence (AI)-based simulation technology to mimic human physiology that pharmaceutical companies can use as a proxy for patients. Researchers and clinicians feed drug data into the simulated model to predict the drug’s exposure in patients and test the safety and efficacy of a drug without any consequences on humans and animals.  For example, in March 2023, Certara Inc., a US-based leader in bio simulation launched Simcyp Simulator Version 22, a physiologically-based pharmacokinetic (PBPK) platform for determining first-in-human dosing, optimizing clinical study design, evaluating new drug formulations and predicting drug-drug interactions (DDIs).  Certara Inc’s Simcyp Animal is a whole-body PBPK modeling platform for rats, dogs, monkeys and mice. It is based on the Simcyp Human Simulator with simplified interfaces and well-validated models.

Opportunities And Recommendations In The Animal Testing And Non-Animal Alternative Testing Market

Opportunities – To take advantage of the opportunities, The Business Research Company recommends the animal testing and non-animal alternative testing companies to focus on using AI to accelerate drug discovery technologies with ethical alternatives, adoption of in silico trials to test efficacy of drugs, use of model organisms in testing, developments in OOC (organ-on-chip) for testing, focus on 3d-printed organs for testing, increasing collaborations and partnerships to reduce animal testing and rising initiatives and grants to promote animal-free testing.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the animal testing and non-animal alternative testing companies to focus on AI-driven drug discovery solutions, focus on in silico trials for drug testing, focus on organ-on-chip tools for advanced testing, focus on 3D-printed organ technologies for enhanced testing, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions and focus on people-centric strategies to target end-users.

Animal Testing And Non-Animal Alternative Testing Market Segmentation

The animal testing and non-animal alternative testing market is segmented by end use industrial application, by end-user applications and by animal type.

By End Use Industrial Application –
The animal testing and non-animal alternative testing market is segmented by industrial application into:
    • a) Basic Research
    • b) Applied Research
    • c) Regulatory testing
    • d) Development of New Diagnostic Methods
    • e) Breeding of Genetically Altered Animals
    • f) Animal Cloning


    • By End-User Applications –
      The animal testing and non-animal alternative testing market is segmented by end-user applications into:
        • a) Cosmetics Industry
        • b) Pharmaceutical Industry
        • c) Medical Device Industry
        • d) Others


        • By Animal Type –
          The animal testing and non-animal alternative testing market is segmented by animal type into:
            • a) Mice
            • b) Rats
            • c) Frogs
            • d) Fish
            • e) Birds
            • f) Guinea pigs
            • g) Hamsters
            • h) Rabbits
            • i) Sheep
            • j) Dogs
            • k) Cats
            • l) Monkeys
            • m) Pigs
            • n) Others


            • By Geography - The animal testing and non-animal alternative testing market is segmented by geography into:
                  o Asia Pacific
                  • • China
                  • • Japan
                  • • Australia
                  o North America
                  • • USA
                  • Canada
                  o Western Europe
                  • • France
                  • • Germany
                  • • UK
                  • Animal Testing And Non-Animal Alternative Testing Market Competitive Landscape

                    Major Competitors are:

                  • BioIVT
                  • MatTek Corporation
                  • Gentronix Limited
                  • Promega Corporation
                  • InSphero
                  • Charles River Laboratories
                  • Cyprotex
                  • EMD Millipore
                  • Japan Tissue Engineering Co., Ltd.
                  • Organ Technologies Co., Ltd.
                  • Certest Biotec
                  • XCellR8

    Table Of Contents

    1 Executive Summary

    2 Table Of Contents

    3 List Of Tables

    4 List Of Figures

    5 Report Structure

    6 Market Characteristics

    6.1 General Market Definition

    6.2 Summary

    6.3 Animal Testing And Non-Animal Alternative Testing Market Definition And Segmentations

    6.3.1 Animal Testing

    6.3.2 Non-Animal Alternative Testing

    6.3.3 Facts About Animals In Research - Functional Resemblances Of Animals To Human Body

    6.4 Market Segmentation By End-Use Industry

    6.4.1 Pharmaceuticals

    6.4.2 Academic Research

    6.4.3 Medical Devices

    6.4.4 Chemicals And Pesticides

    6.4.5 Cosmetics

    6.4.6 Other End Users

    7 Value Chain Analysis

    7.1 Animal Breeders and Suppliers

    7.2 Non-Animal Alternative Testing Technology Developers

    7.3 Regulatory Authorities

    7.4 Alternative Testing Service Providers

    7.5 End-Use Industries

    7.6 Clinical Trials

    8 Non-Animal Alternative Testing Market Trends

    8.1 AI To Accelerate Drug Discovery Technologies With Ethical Alternatives

    8.2 Adoption Of In Silico Trials To Test Efficacy Of Drugs

    8.3 Use Of Model Organisms In Testing

    8.4 Developments In OOC (Organ-On-Chip) For Testing

    8.5 Focus On 3D-Printed Organs For Testing

    8.6 Increasing Collaborations And Partnerships To Reduce Animal Testing

    8.7 Rising Initiatives And Grants To Promote Animal-Free Testing

    9 Cost Analysis For Animal Testing And Alternative Technologies

    9.1 Average Cost Of Laboratory Animals

    9.2 Average Cost Of Non-Animal Alternative Testing Methods

    9.3 Comparative Cost Analysis For Animal Testing And Alternative Methods

    9.4 Costs Involved In Animal Testing, 2021

    10 Animal Testing And Non-Animal Alternative Testing Market Segments

    10.1 By End Use Industrial Application

    10.1.1 Important Areas of Use

    10.1.2 Basic Research

    10.1.3 Applied Research

    10.1.4 Regulatory Testing

    10.1.5 Development Of New Diagnostic Methods

    10.1.6 Breeding Of Genetically Altered Animals

    10.1.7 Animal Cloning

    10.2 End-User Applications

    10.3 Animal Testing Market By Animal Type

    10.3.1 Mice

    10.3.2 Rat

    10.3.3 Frogs

    10.3.4 Fish

    10.3.5 Birds

    10.3.6 Guinea pig

    10.3.7 Hamster

    10.3.8 Rabbits

    10.3.9 Sheep

    10.3.10 Dogs

    10.3.11 Cats

    10.3.12 Monkeys

    10.3.13 Pigs

    10.3.14 Others

    11 Number Of Animals Used In Research, By Country

    11.1 USA

    11.2 Europe

    11.3 United Kingdom (UK)

    11.4 Germany

    11.5 France

    11.6 Australia

    11.7 Canada

    11.8 China

    12 Non-Animal Alternative Testing Technologies By Type And End Use

    12.1 Introduction

    12.2 Types Of Non-Animal Alternative Testing Technologies

    12.2.1 Cell Or Tissue Culture (In-Vitro)

    12.2.2 Major Cell Culture Developers Worldwide

    12.2.3 Organ-On-Chip (OOC)

    12.2.4 Global OOC Market Size And Growth

    12.2.5 OOC Market Drivers And Restraints

    12.2.6 Market Drivers

    12.2.7 Market Restraints

    12.2.8 In-silico (Computer-Based Models)

    12.2.9 Artificial Skin Models (Skin Substitutes)

    12.2.10 Other Technologies

    13 End-User Industries Adoption Of Alternative Testing Technologies

    13.1 Adoption of Alternative Testing Technologies By Type of Industry

    13.1.1 Cosmetics Industry

    13.1.2 Pharmaceutical Industry

    13.1.3 Medical Device Industry

    13.1.4 Others

    13.2 Adoption of 3R’s In USA

    13.2.1 3R Adoption In The Cosmetics Industry

    13.2.2 3R Adoption In The Pharmaceutical Industry

    13.2.3 3R Adoption In The Medical Device Industry

    13.3 Adoption of 3R’s In China

    13.3.1 3R Adoption In The Cosmetics Industry

    13.3.2 3R Adoption In The Pharmaceutical Industry

    13.3.3 3R Adoption In The Medical Device Industry

    13.4 Adoption of 3R’s In Europe

    13.4.1 3R Adoption In The Cosmetics Industry

    13.4.2 3R Adoption In The Pharmaceutical Industry

    13.4.3 3R Adoption In The Medical Device Industry

    14 Global Animal Testing And Non-Animal Testing Market

    14.1 Global Animal Testing Market Size And Growth

    14.1.1 Global Animal Testing Market Value ($ Billion)

    14.1.2 Global Animal Testing Market, By Volume (Million Units)

    14.1.3 Animal Testing Market Drivers

    14.1.4 Animal Testing Market Restraints

    14.2 Global Non-Animal Alternative Testing Market Size And Growth

    14.2.1 Global Non-Animal Alternative Testing Market Value ($ Billion)

    14.2.2 Non-Animal Alternative Testing Market Drivers

    14.2.3 Non-Animal Alternative Testing Market Restraints

    15 Animal Testing And Non-Animal Testing Market, Regional And Country Analysis

    16 USA Animal Testing And Non-Animal Alternative Testing Market

    16.1 USA Animal Testing Market

    16.1.1 USA Animal Testing Market Value ($ Billion)

    16.1.2 USA Animal Testing Market, By Volume (Million Units)

    16.2 USA Non-Animal Alternative Testing Market

    16.2.1 USA Non-Animal Alternative Testing Market Value ($ Billion)

    16.3 USA Animal Testing Market By End Use Industrial Application

    16.3.1 Market By Value And Volume

    16.3.2 122

    16.3.3 Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

    16.4 Regulatory Landscape In The USA

    16.4.1 Regulatory Bodies & Policies

    16.4.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

    16.4.3 USDA & Animal Welfare Act

    16.4.4 ICCVAM

    16.4.5 FDA

    16.4.6 NIH

    16.4.7 Animal Welfare Act (AWA)

    17 Japan Animal Testing And Non-Animal Alternative Testing Market

    17.1 Japan Animal Testing Market

    17.1.1 Japan Animal Testing Market Value ($ Billion)

    17.1.2 Japan Animal Testing Market, By Volume (Million Units)

    17.2 Japan Non-Animal Alternative Testing Market

    17.2.1 Japan Non-Animal Alternative Testing Market Value ($ Billion)

    17.3 Japan Animal Testing Market By End Use Industrial Application

    17.3.1 Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

    17.4 Regulatory Landscape In Japan

    17.4.1 Regulatory Bodies & Policies

    17.4.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

    17.4.3 Law for the Humane Treatment and Management of Animals

    17.4.4 MHLW, MEXT, PMDA And MAFF

    18 China Animal Testing And Non-Animal Alternative Testing Market

    18.1 China Animal Testing Market

    18.1.1 China Animal Testing Market Value ($ Billion)

    18.1.2 China Animal Testing Market, By Volume (Million Units)

    18.2 Regulatory Landscape In China

    18.2.1 Regulatory Bodies & Policies

    18.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

    19 Australia Animal Testing And Non-Animal Alternative Testing Market

    19.1 Australia Animal Testing Market

    19.1.1 Australia Animal Testing Market Value ($ Billion)

    19.1.2 Australia Animal Testing Market, By Volume (Million Units)

    19.2 Regulatory Landscape In Australia

    19.2.1 Regulatory Bodies & Policies

    19.2.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

    20 Europe Animal Testing And Non-Animal Alternative Testing Market

    20.1 Regulatory Landscape In Europe

    20.1.1 EU Directive 2010/63

    20.2 Europe Non-Animal Alternative Testing Market

    20.2.1 Europe Non-Animal Alternative Testing Market Value ($ Billion)

    21 France Animal Testing And Non-Animal Alternative Testing Market

    21.1 France Animal Testing Market

    21.1.1 France Animal Testing Market Value ($ Billion)

    21.1.2 France Animal Testing Market, By Volume (Million Units)

    21.2 France Animal Testing Market By End Use Industrial Application

    21.2.1 Market By Value

    21.2.2 160

    21.3 Regulatory Landscape In France

    21.3.1 Regulatory Bodies & Policies

    21.3.2 Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

    22 Germany Animal Testing And Non-Animal Alternative Testing Market

    22.1 Germany Animal Testing Market

    22.1.1 Germany Animal Testing Market Value ($ Billion)

    22.1.2 Germany Animal Testing Market, By Volume (Million Units)

    22.2 Germany Animal Testing Market By End Use Industrial Application

    22.2.1 Market By Value

    22.2.2 168

    22.3 Regulatory Landscape In Germany

    22.3.1 Regulatory Bodies & Policies

    22.3.2 Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

    23 UK Animal Testing And Non-Animal Alternative Testing Market

    23.1 UK Animal Testing Market

    23.1.1 UK Animal Testing Market Value ($ Billion)

    23.1.2 UK Animal Testing Market, By Volume (Million Units)

    23.2 UK Animal Testing Market By End Use Industrial Application

    23.2.1 Market By Value

    23.2.2 176

    23.3 Regulatory Landscape in United Kingdom (UK)

    23.3.1 Regulatory Bodies & Policies

    23.3.2 Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

    24 Canada Animal Testing And Non-Animal Alternative Testing Market

    24.1 Canada Animal Testing Market

    24.1.1 Canada Animal Testing Market Value ($ Billion)

    24.1.2 Canada Animal Testing Market, By Volume (Million Units)

    24.2 Regulatory Landscape In Canada

    24.2.1 Regulatory Bodies & Policies

    24.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

    25 Rest of the World (RoW) Animal Testing And Non-Animal Alternative Testing Market

    25.1 Rest of the World (RoW) Animal Testing Market

    25.1.1 Rest of the World (RoW) Animal Testing Market Value ($ Billion)

    25.1.2 Rest of the World (RoW) Animal Testing Market, By Volume (Million Units)

    25.2 Regulatory Landscape In Rest of the World (RoW)

    25.2.1 Regulatory Bodies & Policies

    25.2.2 Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

    26 Non-Animal Alternatives Testing Competitive Landscape And Company Profiles

    26.1 Company Profiles

    26.2 Bio-Rad Laboratories, Inc.

    26.2.1 Company Overview

    26.2.2 Products And Services

    26.2.3 Business Strategy

    26.2.4 Financial Overview

    26.3 SGS SA

    26.3.1 Company Overview

    26.3.2 Products And Services

    26.3.3 Business Strategy

    26.3.4 Financial Overview

    26.4 Abbott Laboratories

    26.4.1 Company Overview

    26.4.2 Products And Services

    26.4.3 Financial Overview

    26.5 Evotec SE

    26.5.1 Company Overview

    26.5.2 Products And Services

    26.5.3 Business Strategy

    26.5.4 Financial Overview

    26.6 Emulate, Inc

    26.6.1 Company Overview

    26.6.2 Products And Services

    26.6.3 Business Strategy

    26.6.4 Financial Overview

    26.7 USA Non-Animal Alternative Testing Market Competitive Landscape

    26.8 Company Profiles

    26.9 Charles River Laboratories

    26.9.1 Company Overview

    26.9.2 Products And Services

    26.9.3 Business Strategy

    26.9.4 Financial Overview

    26.10 Cyprotex

    26.10.1 Company Overview

    26.10.2 Products And Services

    26.10.3 Business Strategy

    26.10.4 Financial Overview

    26.11 Emulate, Inc

    26.11.1 Company Overview

    26.11.2 Products And Services

    26.11.3 Business Strategy

    26.11.4 Financial Overview

    26.12 BioIVT

    26.12.1 Company Overview

    26.12.2 Products And Services

    26.12.3 Business Strategy

    26.12.4 Financial Overview

    26.13 EMD Millipore

    26.13.1 Company Overview

    26.13.2 Products And Services

    26.13.3 Business Strategy

    26.13.4 Financial Overview

    26.14 Japan Non-Animal Alternative Testing Market Competitive Landscape

    26.15 Company Profiles

    26.16 Japan Tissue Engineering Co., Ltd. (J-TEC)

    26.16.1 Company Overview

    26.16.2 Products And Services

    26.16.3 Business Strategy

    26.16.4 Financial Overview

    26.17 ReproCell Inc

    26.17.1 Company Overview

    26.17.2 Products And Services

    26.17.3 Financial Overview

    26.18 Organ Technologies Co, Ltd

    26.18.1 Company Overview

    26.18.2 Products And Services

    26.19 Europe Non-Animal Alternative Testing Market Competitive Landscape

    26.20 Company Profiles

    26.21 CN Bio Innovations, Ltd

    26.21.1 Company Overview

    26.21.2 Products And Services

    26.21.3 Business Strategy

    26.21.4 Financial Overview

    26.22 Cyprotex

    26.22.1 Company Overview

    26.22.2 Products And Services

    26.22.3 Business Strategy

    26.22.4 Financial Overview

    26.23 Certest Biotec

    26.23.1 Company Overview

    26.23.2 Products And Services

    26.23.3 Financial Overview

    26.24 XCellR8

    26.24.1 Company Overview

    26.24.2 Products And Services

    26.24.3 Financial Overview

    26.25 Gentronix Ltd

    26.25.1 Company Overview

    26.25.2 Products And Services

    26.25.3 Financial Overview

    27 Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies

    27.1 Global Animal Testing Market In 2035 – Geographies Offering Most New Opportunities

    27.2 Global Non-Animal Alternative Testing Market In 2035 – Geographies Offering Most New Opportunities

    27.3 Global Animal Testing And Non-Animal Alternative Testing Market In 2035 – Segments Offering Most New Opportunities

    27.4 Global Animal Testing And Non-Animal Alternative Testing Market In 2025 – Growth Strategies

    27.4.1 Non-Animal Alternative Testing Market Trend Based Strategies

    27.4.2 Competitor Strategies

    28 Animal Testing And Non-Animal Alternative Testing Market, Conclusions And Recommendations

    28.1 Conclusions

    28.2 Recommendations

    28.2.1 Product

    28.2.2 Place

    28.2.3 Price

    28.2.4 Promotion

    28.2.5 People

    29 Appendix

    29.1 Geographies Covered

    29.2 Glossary

    29.3 Market Data Sources

    29.4 Research Methodology

    29.4.1 OCED Accepted In Vito Tests

    29.5 Currencies

    29.6 The Business Research Company

    29.7 Copyright and Disclaimer

List Of Tables

    Table 1: Estimated Average Cost Of Animals, 2023 ($)  
  • Table 2: Estimated Cost Analysis For Animal Testing And Non-Animal Alternative Testing Methods, 2022 ($)  
  • Table 3: Estimated Number of Legally Protected Animals In Research Laboratories in the USA, 2021  
  • Table 4: Estimated Number of Animals Used in Research, Europe, 2022  
  • Table 5: Estimated Number of Animals Used in Research, UK, 2022  
  • Table 6: Number of Animals Used in Research, Germany, 2022  
  • Table 7: Number of Animals Used in Research, France, 2022  
  • Table 8: Number of Animals Used in Research, Canada, 2022  
  • Table 9: Number of Animals Used in Research, China, 2022  
  • Table 10: Global OOC Market, Historic Market Size, 2019– 2023, $ Million  
  • Table 11:  Organ-On-Chips As An Alternative To Animal Testing, Major OOC Developers Worldwide  
  • Table 12: Computer Simulation As An Alternative to Animal Testing, Major In-Silico Model Developers  
  • Table 13: Artificial Skin Model As An Alternative To Animal Testing, Major Artificial Skin Model Developers  
  • Table 14: Non-Animal Alternative Testing Methods Accepted By The US Agencies  
  • Table 15: Non-Animal Alternative Testing Methods Accepted By The China Agencies  
  • Table 16: Non-Animal Alternative Testing Methods Accepted By The European Commission  
  • Table 17: Global Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 18: Global Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 19: Global Non-Animal Alternative Testing Market Size, 2019– 2035, $ Billion  
  • Table 20: USA Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 21: USA Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 22: USA Non-Animal Alternative Testing Market Size, 2019– 2035, $ Billion  
  • Table 23: USA Animal Testing Market, By End Use Industrial Application, By Value ($ Billion), And By Volume (Millions Units) 2023  
  • Table 24: USA Animal Testing Market, Estimated Share of Top 5 Companies (In Each Industrial Application), 2022  
  • Table 25: Laboratory Animal Testing Regulatory Landscape In The USA  
  • Table 26: Japan Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 27: Japan Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 28: Japan Non-Animal Alternative Testing Market Size, 2019– 2035, $ Billion  
  • Table 29: Japan Animal Testing Market, Estimated Share of Top 5 Companies (In Each Industrial Application), 2022  
  • Table 30: Laboratory Animal Testing Regulatory Landscape In Japan  
  • Table 31: China Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 32: China Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 33: Laboratory Animal Testing Regulatory Landscape In China  
  • Table 34: Australia Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 35: Australia Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 36: Laboratory Animal Testing Regulatory Landscape In Australia  
  • Table 37: Europe Non-Animal Alternative Testing Market Size, 2019– 2035, $ Billion  
  • Table 38: France Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 39: France Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 40: France Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Table 41: Laboratory Animal Testing Regulatory Landscape In France  
  • Table 42: Germany Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 43: Germany Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 44: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Table 45: Laboratory Animal Testing Regulatory Landscape In Germany  
  • Table 46: UK Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 47: UK Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 48: UK Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Table 49: Laboratory Animal Testing Regulatory Landscape In The UK  
  • Table 50: Canada Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 51: Canada Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 52: Laboratory Animal Testing Regulatory Landscape In Canada  
  • Table 53: Rest of the World (RoW) Animal Testing Market Size, 2019– 2035, $ Billion  
  • Table 54: Rest of the World (RoW) Animal Testing Market, Volume, 2019– 2035, Million Units  
  • Table 55: Laboratory Animal Testing Regulatory Landscape In RoW  
  • Table 56: Global Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Table 57: Bio-Rad Laboratories, Inc – Financial Overview, 2018 – 2022, $ Billion  
  • Table 58: SGS SA – Financial Overview, 2018 – 2022, $ Billion  
  • Table 59: Abbott Laboratories – Financial Overview, 2018 – 2022, $ Billion  
  • Table 60: Evotec SE – Financial Overview, 2018 – 2022, $ Billion  
  • Table 61: Emulate, Inc – Financial Overview, 2022, $ Million  
  • Table 62: US Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Table 63: Charles River Laboratories – Financial Overview, 2018 – 2022, $ Billion  
  • Table 64: Cyprotex – Financial Overview, 2022, $ Million  
  • Table 65: Emulate, Inc – Financial Overview, 2022, $ Million  
  • Table 66: BioIVT – Financial Overview, 2022, $ Million  
  • Table 67: EMD Millipore – Financial Overview, 2022, $ Million  
  • Table 68: Japan Tissue Engineering Co., Ltd – Financial Overview, 2018 – 2022, $ Billion  
  • Table 69: ReproCell Inc – Financial Overview, 2022, $ Million  
  • Table 70:  Europe Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Table 71: CN Bio Innovations – Financial Overview, 2022, $ Million  
  • Table 72: Cyprotex – Financial Overview, 2022, $ Million  
  • Table 73: Certest Biotec – Financial Overview, 2022, $ Million  
  • Table 74: XCellR8 – Financial Overview, 2022, $ Million  
  • Table 75: Gentronix – Financial Overview, 2022, $ Million  
  • Table 76: Global Animal Testing Market Size Gain ($ Billion), 2023 – 2035, By Country  
  • Table 77: Global Non-Animal Alternative Market Size Gain ($ Billion), 2023 – 2035, By Country  
  • Table 78: Global Animal Testing And Non-Animal Alternative Testing Market Size Gain ($ Billion), Segmentation By Type, 2023 – 2035  
  • Table 79: Market Data Sources  
  • Table 80: OECD Accepted In-Vitro Tests For Medical Devices  

List Of Figures

    Figure 1: Global Animal Testing Segmentation By End-Use Industry  
  • Figure 2: Value Chain Analysis For Animal Testing & Non-Animal Alternative Testing Market  
  • Figure 3:  Global OOC Market, Historic Market Size, 2019– 2023, $ Million  
  • Figure 4:  Global Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 5:  Global Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 6:  Global Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 7: USA Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 8: USA Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 9:  USA Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 10:  USA Animal Testing Market, By End Use Industrial Application, By Value ($ Billion), And By Volume (Millions Units) 2023  
  • Figure 11: Japan Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 12: Japan Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 13:  Japan Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 14: China Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 15: China Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 16: Australia Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 17: Australia Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 18:  Europe Non-Animal Alternative Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 19: France Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 20: France Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 21:  France Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Figure 22: Germany Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 23: Germany Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 24:  Germany Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Figure 25: UK Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 26: UK Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 27:  UK Animal Testing Market, By End Use Industrial Application, By Value, 2023, $ Billion  
  • Figure 28: Canada Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 29: Canada Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 30: Rest of the World (RoW) Animal Testing Market Size, 2019 – 2035, $ Billion  
  • Figure 31: Rest of the World (RoW) Animal Testing Market, Volume, 2019 – 2035, Million Units  
  • Figure 32: Global Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Figure 33: Bio-Rad Laboratories, Inc – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 34: SGS SA – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 35: Abbott Laboratories. – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 36: Evotec SE – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 37: US Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Figure 38: Charles River Laboratories – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 39: Japan Tissue Engineering Co., Ltd – Financial Overview, 2018 – 2022, $ Billion  
  • Figure 40: Europe Non-Animal Alternatives Testing Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)  
  • Figure 41: Geographic Regions Covered  
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the animal testing and non-animal alternative testing market?

The animal testing market consists of the total expenses incurred by end-use entities that use animals for testing their products. End-use entities include academic research institutions and various industries (such as pharmaceuticals, medical devices, chemicals & pesticides and cosmetics,) that conduct animal testing during product development. The non-animal alternative testing market is the total expenses incurred by end-use entities that use alternative technologies instead of animals for testing their products. request a sample here

How will the animal testing and non-animal alternative testing market drivers and restraints affect animal testing and non-animal alternative testing market dynamics? What forces will shape the animal testing and non-animal alternative testing industry go

The animal testing market growth is aided by the need for preclinical studies for the approval of therapeutics. However, some animal testing market restraints include the high cost of animal studies. The non-animal alternative testing market growth is aid request a sample here

What is the forecast market size of the animal testing and non-animal alternative testing market?

The global animal testing market is valued at $10.74 billion in 2019 having grown at a CAGR (compound annual growth rate) of almost 4.27%. request a sample here

How is the animal testing and non-animal alternative testing market segmented?

The global animal testing market is segmented-
a) By End-Use
request a sample here

Which region has largest share, and what is the market size and growth by geography according to the animal testing and non-animal alternative testing global market report?

For more detail on this, request a sample here.

Who are the key players of the global animal testing and non-animal alternative testing market?

Top competitors in the global non-animal alternative testing market are Emulate, Inc; Organovo Holdings, Inc; MatTek Corporation; EMD Millipore; ReproCell Inc. request a sample here.

What are the key trends in the global animal testing and non-animal alternative testing market?

Major trends global non-animal alternative testing market include increasing collaborations & partnerships to reduce animal testing. request a sample here.

What are the major opportunities in the animal testing and non-animal alternative testing market and the approaches companies can take to take advantage of them?

For this and further detailed insights on the market, request a sample here. request a sample here.

How does the animal testing and non-animal alternative testing market relate to the overall economy and other similar markets?